ROYAL BANK OF CANADA - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 24 filers reported holding APTEVO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$3,000
+50.0%
1,700
+138.1%
0.00%
Q3 2022$2,000
-33.3%
7140.0%0.00%
Q2 2022$3,000
-66.7%
714
-55.8%
0.00%
Q1 2022$9,000
-30.8%
1,6140.0%0.00%
Q4 2021$13,000
-48.0%
1,6140.0%0.00%
Q3 2021$25,000
-30.6%
1,6140.0%0.00%
Q2 2021$36,000
+5.9%
1,614
+44.9%
0.00%
Q1 2021$34,000
+30.8%
1,114
+56.0%
0.00%
Q4 2020$26,000
+420.0%
7140.0%0.00%
Q3 2020$5,000
-16.7%
714
-5.7%
0.00%
Q2 2020$6,000
+100.0%
757
-9.8%
0.00%
Q1 2020$3,0008390.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,760,000$64,504,0009.85%
Stonepine Capital Management, LLC 18,280$670,0000.51%
Ghost Tree Capital, LLC 50,000$1,833,0000.41%
Anson Funds Management LP 45,462$1,666,0000.34%
RTW INVESTMENTS, LP 288,236$10,564,0000.18%
Dynamic Technology Lab Private Ltd 13,202$484,0000.08%
Alyeska Investment Group, L.P. 49,601$1,818,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 11,493$421,0000.02%
PURA VIDA INVESTMENTS, LLC 8,203$301,0000.01%
Renaissance Technologies 254,423$9,325,0000.01%
View complete list of APTEVO THERAPEUTICS INC shareholders